These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26686425)

  • 1. Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities.
    Au JL; Yeung BZ; Wientjes MG; Lu Z; Wientjes MG
    Adv Drug Deliv Rev; 2016 Feb; 97():280-301. PubMed ID: 26686425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
    Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
    Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery and transport to solid tumors.
    Jang SH; Wientjes MG; Lu D; Au JL
    Pharm Res; 2003 Sep; 20(9):1337-50. PubMed ID: 14567626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanoparticle-based delivery systems modulate the tumor microenvironment in pancreatic cancer for enhanced therapy.
    Jia M; Zhang D; Zhang C; Li C
    J Nanobiotechnology; 2021 Nov; 19(1):384. PubMed ID: 34809634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling the Tumor Microenvironment with Emerging Nanotherapeutics.
    Chen Q; Liu G; Liu S; Su H; Wang Y; Li J; Luo C
    Trends Pharmacol Sci; 2018 Jan; 39(1):59-74. PubMed ID: 29153879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the Potential of Nanotherapeutics in Targeting Tumor Microenvironment for Cancer Therapy.
    Muntimadugu E; Kommineni N; Khan W
    Pharmacol Res; 2017 Dec; 126():109-122. PubMed ID: 28511988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of current nanoparticle and targeting moieties for the delivery of cancer therapeutics.
    Steichen SD; Caldorera-Moore M; Peppas NA
    Eur J Pharm Sci; 2013 Feb; 48(3):416-27. PubMed ID: 23262059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle mediated cancer immunotherapy.
    Gupta J; Safdari HA; Hoque M
    Semin Cancer Biol; 2021 Feb; 69():307-324. PubMed ID: 32259643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering extracellular matrix to improve drug delivery for cancer therapy.
    He X; Yang Y; Li L; Zhang P; Guo H; Liu N; Yang X; Xu F
    Drug Discov Today; 2020 Sep; 25(9):1727-1734. PubMed ID: 32629171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologically based strategies for overcoming in vivo barriers with functional nano-delivery systems.
    Ahmadzadeh R; Taheri SA; Mohammadi N; Hjazi A; Menon SV; Kadhum WR; Kumar A; Shakir MN; Shayan FK; Shirinkami N
    J Biochem Mol Toxicol; 2024 Aug; 38(8):e23782. PubMed ID: 39115384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
    Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
    Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reengineering the Physical Microenvironment of Tumors to Improve Drug Delivery and Efficacy: From Mathematical Modeling to Bench to Bedside.
    Stylianopoulos T; Munn LL; Jain RK
    Trends Cancer; 2018 Apr; 4(4):292-319. PubMed ID: 29606314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics.
    Prakash J; Shaked Y
    Cancer Discov; 2024 Aug; 14(8):1375-1388. PubMed ID: 39091205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle targeting of anti-cancer drugs that alter intracellular signaling or influence the tumor microenvironment.
    Kanapathipillai M; Brock A; Ingber DE
    Adv Drug Deliv Rev; 2014 Dec; 79-80():107-18. PubMed ID: 24819216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities.
    Kirtane AR; Kalscheuer SM; Panyam J
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1731-47. PubMed ID: 24036273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to drug delivery in interventional oncology.
    Sheth RA; Hesketh R; Kong DS; Wicky S; Oklu R
    J Vasc Interv Radiol; 2013 Aug; 24(8):1201-7. PubMed ID: 23735316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrostatic driven transport enhances penetration of positively charged peptide surfaces through tumor extracellular matrix.
    Mohanty RP; Liu X; Ghosh D
    Acta Biomater; 2020 Sep; 113():240-251. PubMed ID: 32428687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Microenvironment-Enabled Nanotherapy.
    Wang L; Huo M; Chen Y; Shi J
    Adv Healthc Mater; 2018 Apr; 7(8):e1701156. PubMed ID: 29283221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation-assisted strategies provide new perspectives to improve the nanoparticle delivery to tumor.
    Zhang D; He J; Zhou M
    Adv Drug Deliv Rev; 2023 Feb; 193():114642. PubMed ID: 36529190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.